Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
10/2000
10/25/2000EP1045838A1 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid
10/25/2000EP1045834A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/24/2000US6136842 Sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives
10/24/2000US6136834 Tetrazole compounds and pharmaceutical agents containing such derivative
10/24/2000US6136223 Metal ligand containing bleaching compositions
10/18/2000EP1044966A1 (Poly)thia-alkyne compounds and their derivatives, compositions containing them and their use
10/18/2000EP1044187A1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia
10/18/2000EP1043994A1 Method for treating multiple sclerosis
10/18/2000CN1270518A Therapeutic or prophylactic agent for glomerulopathy
10/17/2000US6133442 For the treatment of disorders which are associated with endothelin activities, especially circulatory disorders such as hypertension, ischaemia, vasospasms and angina pectoris
10/17/2000US6133302 Kynurenine-3-hydroxylase enzyme inhibitory activity, an enzyme of the kynurenine (kyn) pathway; compounds such as 5-(3-(3-fluorophenyl)-3-oxo-propyl)-1h-tetrazole; for treatment of neuropathological processes
10/17/2000US6133259 Diagnosis of alzheimer's disease
10/12/2000WO2000059895A1 Pesticidal tetrazole derivatives
10/12/2000WO1998025597A3 Method for treating and preventing heart failure and ventricular dilatation
10/12/2000DE19914101C1 Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik Perfluoralkylamide, their preparation and their use in the diagnosis
10/12/2000CA2369541A1 Pesticidal tetrazole derivatives
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/11/2000EP1042299A1 Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/11/2000EP0773930B1 Aromatic amino ethers as pain relieving agents
10/05/2000WO2000058280A1 Carbocyclic sulfonamide derivatives
10/05/2000WO2000058278A1 β-AMINO ACID DERIVATIVES
10/04/2000EP1041064A2 N-substituted alpha aminoacid amides as calcium channel modulators
10/04/2000EP1040112A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/04/2000EP1040098A1 Integrin receptor antagonists
10/04/2000EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
10/03/2000US6127536 Reacting together separate ethyl acetate solutions of malonyl dihalide and 1,2-bis(aminoalkylamido-)benzene within vessel containing third ethyl acetate solution including acid scavenger
09/2000
09/28/2000WO2000056743A1 Pharmaceutical compositions comprising metal complexes
09/28/2000WO2000056723A1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics
09/28/2000CA2367282A1 Pharmaceutical compositions comprising metal complexes
09/28/2000CA2362703A1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics
09/27/2000EP1037880A1 Retinoic acid mimetic anilides
09/27/2000EP1037868A2 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS
09/27/2000CN1268117A Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis
09/27/2000CN1056835C Novel selective aromatase inhibiting compounds
09/26/2000US6124251 Toilet bowl cleaning tablet
09/26/2000CA1341102C Tetra-aza macrocycles and metal complexes thereof
09/21/2000WO2000054729A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000WO2000039077A3 Thyroid receptor ligands
09/21/2000CA2367461A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/19/2000US6121322 Antiinflammatory agents
09/19/2000US6121319 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/19/2000US6121281 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
09/19/2000US6120941 Anion receptor compounds for non-aqueous electrolytes
09/14/2000WO2000053588A1 A process for the preparation of 1,4,7,10-tetraazacyclododecane
09/14/2000WO2000053583A1 Inhibitors of protein tyrosine phosphatase
09/14/2000WO1999063999A8 H1-histamine receptor antagonists
09/14/2000CA2366308A1 Inhibitors of protein tyrosine phosphatase
09/13/2000EP1035118A1 Method for preparing 5,5'-bi-1H-tetrazole salt
09/13/2000CN1266428A Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
09/13/2000CN1266368A Heterocyclic vinylethers against neurological disorders
09/13/2000CN1266054A Aryl carboxylic acid and tetrazole derivant
09/08/2000WO2000051993A2 Dihetero-substituted metalloprotease inhibitors
09/08/2000CA2366954A1 Dihetero-substituted metalloprotease inhibitors
09/06/2000EP1032557A1 Method for preparing bromomethyl-biphenyl derivatives
09/06/2000CN1056162C Polyaminated ligands and metal complexes thereof
09/05/2000US6114521 Reacting 2a,4a,6a,8a-decahydro-tetraazacyclopent(fg)acenaphthylene with bromine to form intermediate, hydrolyzing the intermediate to form 1,4,7,10-tetraazacyclododecane
09/05/2000US6114175 Amyloid-binding compounds which are non-azo derivatives of chrysamine g to determine degree of brain deposits quantitatively characterized by amyloidosis; down's syndrome; prevent cell degeneration; radioactive imaging
09/05/2000CA2039399C Dual functioning excipient for metal chelate contrast agents
08/2000
08/31/2000WO2000050390A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
08/31/2000CA2364804A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
08/30/2000EP1030843A1 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
08/30/2000EP0749418B1 L-n6 -(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors
08/29/2000US6111114 4-bromomethyldiphenyl substituted by 2'-cyano,-carboxy, carbonyloxy or carboxyamide prepared by brominating the corresponding 4-methyl compound using bromine or aqueous hydrobromine solution in the presence of hydrogen peroxide
08/29/2000US6110963 Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
08/29/2000US6110946 An enzyme inhibitors of retroviral aspartate protease for the treatment of aids
08/23/2000EP1029541A1 Therapeutic or prophylactic agent for glomerulopathy
08/23/2000EP1028941A2 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
08/23/2000EP1028716A1 Method for treating and preventing heart failure and ventricular dilatation
08/23/2000EP0805795B1 Novel aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides
08/23/2000EP0637297B1 Compounds having selectivity for retinoid x receptors
08/23/2000CN1263889A Monoclinic system sheet crystal tazhanot
08/17/2000WO2000047554A2 INHIBITORS OF FACTOR Xa
08/17/2000WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
08/17/2000CA2362375A1 Alkenyl and alkynyl compounds as inhibitors of factor xa
08/17/2000CA2361428A1 Inhibitors of factor xa
08/16/2000EP1028111A1 Amide derivatives or salts thereof
08/16/2000EP0703790B1 Iodinated paramagnetic chelates, and their use as contrast agents
08/16/2000CN1263522A Compounds and methods for inhibition of expression of VCAM-1
08/16/2000CN1263462A Monoesters of probucol for treatment of cardiovascular and inflammatory disease
08/10/2000WO2000046189A1 Sulfonamide derivatives having cyclic structures
08/10/2000WO2000046184A1 N2-phenylamidine derivatives
08/10/2000WO2000045814A1 Methods and compositions to enhance white blood cell count
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/08/2000US6100404 Erythromycin compounds
08/08/2000US6100394 Long-lived homogenous oxidation catalysts
08/08/2000US6099586 Metal ligand containing bleaching compositions
08/03/2000WO2000044731A1 Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors
08/02/2000CN1261906A Alkyl, alkenyl and alkynyl chrysamine G derivatives for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
08/01/2000US6096774 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, intiators and gas generators
07/2000
07/27/2000WO2000043372A1 Acyl derivatives which treat vla-4 related disorders
07/27/2000WO2000043369A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors
07/27/2000CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/25/2000US6093735 Selective β-3 adrenergic agonists
07/20/2000WO2000042029A1 1-heterocycle substituted diarylamines
07/20/2000CA2355374A1 1-heterocycle substituted diarylamines
07/19/2000EP1019531A1 A method to assay enzymatic covalent bond formation and cleavage
07/19/2000EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 97